Gfap derivatives for stroke diagnostics
OwnerCiaran Richardson, Ivan McConnell +2inventors
InventorsCiaran Richardson, Ivan McConnell, John Lamont, Stephen Peter Fitzgerald
Life of this patent
Estimating the term…
Abstract
Described are methods and kits for diagnosing stroke using GFAP derivatives.
Claims19
An immunoanalytical method of diagnosing or supporting the diagnosis of stroke in a subject comprising taking a sample from the subject and measuring the amount of a GFAP derivative present in the sample the method incorporating an antibody which binds to an epitope incorporated in the sequence ETRASERAEMME of a GFAP derivative, in which an amount of a GFAP derivative in the sample bound by the antibody which is greater than the amount of a GFAP control is indicative of stroke.
A method comprising using GFAP derivatives as markers of haemorrhagic stroke, haemorrhagic transformation or fatal ischaemic stroke.
An antibody which binds to an epitope of a GFAP species incorporated in the sequence ETRASERAEMME.
A method of using a capture and detector antibody each binding to a discrete epitope of non-overlapping amino acid residues comprised within the sequence 60 to 383 corresponding to GFAP Uniprot numbers P14136-1, P14136-2, and P14136-3 in an immunoassay method for diagnosing or supporting the diagnosis of stroke.
Dependencies are inferred from the claim text.